Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives01:35

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives

2.6K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.6K
Nucleic Acids02:43

Nucleic Acids

49.9K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
49.9K
Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Titration of a Polyprotic Acid02:08

Titration of a Polyprotic Acid

104.1K
A polyprotic acid contains more than one ionizable hydrogen and undergoes a stepwise ionization process.  If the acid dissociation constants of the ionizable protons differ sufficiently from each other, then the titration curve for such polyprotic acid generates a distinct equivalence point for each of its ionizable hydrogens. Therefore, titration of a diprotic acid results in the formation of two equivalence points, whereas the titration of a triprotic acid results in the formation of three...
104.1K
Amino acids03:42

Amino acids

104.7K
Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
104.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Supportive Care Needs Among Pretreatment Head and Neck Cancer Patients According to Smoking Status: A Cross-Sectional Study With Nested Analyses.

Laryngoscope investigative otolaryngology·2026
Same author

Stimuli-responsive STING nanovaccine for systemic therapy of HPV-induced cancers.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Protocol for integrating immunohistochemistry and H&E annotations with Xenium data at single-cell resolution.

STAR protocols·2025
Same author

A Multi-Threshold Micelle Improves Tumor Accumulation and STING Immunotherapy.

Journal of the American Chemical Society·2025
Same author

HYHOPE: A Phase 1 Study of Deintensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer.

International journal of radiation oncology, biology, physics·2025

Video Experimental Relacionado

Updated: Jan 23, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.6K

Activación de la Interleucina-2 para Terapia contra el Cáncer Mediante Nanopartículas con Sensibilidad al pH Severo

Qiang Feng1, Raymundo Pantoja2, Jacqueline G Lopez3

  • 1Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, USA; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Cell reports. Medicine
|January 21, 2026
PubMed
Resumen

Un novedoso sistema de nanopartículas activa la Interleucina-2 (IL-2) específicamente en tumores utilizando polímeros ultrasensibles al pH. Este enfoque reduce la toxicidad sistémica y mejora la eficacia de la inmunoterapia contra el cáncer.

Palabras clave:
inmunoterapia contra el cáncerterapia con citoquinasingeniería inmunológicatoxicidad relacionada con el sistema inmunitariointerleucina-2nanopartícula sensible al pH

Más Videos Relacionados

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Videos de Experimentos Relacionados

Last Updated: Jan 23, 2026

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Área de la Ciencia:

  • Biotecnología; Inmunoterapia; Ciencia de Materiales

Sus antecedentes:

  • La Interleucina-2 (IL-2) muestra promesa en la inmunoterapia contra el cáncer, pero tiene una ventana terapéutica estrecha, lo que limita su aplicación clínica.; Las estrategias existentes, como las proteínas de fusión IL-2-Fc y los profármacos covalentes, enfrentan desafíos con la toxicidad sistémica, la disminución de la potencia y la aplicabilidad.; La activación tumoral específica de IL-2 es crucial para mejorar su índice terapéutico.

Objetivo del estudio:

  • Desarrollar un sistema de nanopartículas no covalente para la activación tumoral específica de IL-2 utilizando polímeros ultrasensibles al pH (UPS).; Evaluar la seguridad y eficacia de la nanopartícula UPS/IL-2-Fc para reducir la toxicidad sistémica manteniendo la actividad antitumoral.; Dilucidar los mecanismos subyacentes a los efectos protectores de la activación de IL-2 desencadenada por el pH.

Principales métodos:

  • Formulación de nanopartículas utilizando polímeros ultrasensibles al pH (UPS) validados clínicamente e IL-2-Fc.; Evaluación de la estabilidad y disociación de las nanopartículas a pH fisiológico y ácido específico del tumor.; Evaluación de los marcadores de toxicidad sistémica (p. ej., interferón-γ, síndrome de fuga vascular) y la eficacia antitumoral en modelos preclínicos.

Principales resultados:

  • La nanopartícula UPS/IL-2-Fc se mantuvo estable a pH fisiológico, pero se disoció y activó la IL-2 a pH tumoral ácido (< 5.3).; Esta activación desencadenada por el pH redujo significativamente el interferón-γ circulante (más de 100 veces) y previno el síndrome de fuga vascular.; Se conservó la eficacia antitumoral, lo que demuestra el potencial terapéutico de la administración dirigida de IL-2.; Los estudios mecanísticos indicaron que el blindaje dependiente del pH y la depuración por macrófagos contribuyeron al efecto protector.

Conclusiones:

  • Un sistema de nanopartículas no covalente y sensible al pH permite la activación tumoral específica de IL-2, superando las limitaciones de los enfoques tradicionales.; Esta estrategia de bioingeniería reduce significativamente la toxicidad sistémica asociada con la inmunoterapia con IL-2.; La nanopartícula UPS/IL-2-Fc representa una plataforma prometedora para mejorar la inmunoterapia contra el cáncer con una ventana terapéutica más amplia.